{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:40:59Z","timestamp":1764002459750,"version":"3.44.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jns.2021.117605","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T11:32:32Z","timestamp":1627990352000},"page":"117605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Neurology of the acute hepatic porphyrias"],"prefix":"10.1016","volume":"428","author":[{"given":"Miguel","family":"Oliveira Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Leal Rato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2021.117605_bb0005","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1056\/NEJMra1608634","article-title":"Porphyria","volume":"377","author":"Bissell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2021.117605_bb0010","first-page":"307","article-title":"The neuropathy of acute intermittent porphyria","volume":"38","author":"Ridley","year":"1969","journal-title":"Q. J. Med."},{"key":"10.1016\/j.jns.2021.117605_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-199201000-00001","article-title":"Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases","volume":"71","author":"Kauppinen","year":"1992","journal-title":"Med."},{"key":"10.1016\/j.jns.2021.117605_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.md.0000152454.56435.f3","article-title":"An analysis of 112 acute porphyric attacks in Cape Town, South Africa: evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity","volume":"84","author":"Hift","year":"2005","journal-title":"Med."},{"key":"10.1016\/j.jns.2021.117605_bb0025","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10545-012-9544-4","article-title":"The incidence of inherited porphyrias in Europe","volume":"36","author":"Elder","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.jns.2021.117605_bb0030","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.amjmed.2014.06.036","article-title":"Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium","volume":"127","author":"Bonkovsky","year":"2014","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jns.2021.117605_bb0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-2008-1040701","article-title":"Neurologic manifestations of acute porphyria","volume":"2","author":"Bonkowsky","year":"1982","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jns.2021.117605_bb0040","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","article-title":"Porphyrias","volume":"375","author":"Puy","year":"2010","journal-title":"Lancet."},{"key":"10.1016\/j.jns.2021.117605_bb0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2007-1007139","article-title":"Acute porphyrias: pathogenesis of neurological manifestations","volume":"18","author":"Meyer","year":"1998","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jns.2021.117605_bb0050","article-title":"Experimental porphyric neuropathy: a preliminary report","volume":"8","author":"Sima","year":"1981","journal-title":"Can. J. Neurol. Sci.\/J. Can. Des Sci. Neurol."},{"year":"2014","series-title":"Porphyria and its Neurologic Manifestations","author":"Tracy","key":"10.1016\/j.jns.2021.117605_bb0055"},{"key":"10.1016\/j.jns.2021.117605_bb0060","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jocn.2003.08.007","article-title":"Epilepsy and porphyria: new perspectives","volume":"11","author":"Solinas","year":"2004","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2021.117605_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/280514a0","article-title":"\u03b4-Aminolaevulinic acid is a potent agonist for GABA autoreceptors","volume":"280","author":"Brennan","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.jns.2021.117605_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2006.06289.x","article-title":"Modern diagnosis and management of the porphyrias","volume":"135","author":"Sassa","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jns.2021.117605_bb0075","doi-asserted-by":"crossref","DOI":"10.3109\/07853899409147324","article-title":"Treatment of the Porphyrias","volume":"26","author":"Kauppinen","year":"1994","journal-title":"Ann. Med."},{"key":"10.1016\/j.jns.2021.117605_bb0080","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/bjh.14459","article-title":"Update review of the acute porphyrias","volume":"176","author":"Stein","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jns.2021.117605_bb0085","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jocn.2011.01.003","article-title":"The neurologic manifestations of the acute porphyrias","volume":"18","author":"Simon","year":"2011","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2021.117605_bb0090","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-018-0867-1","article-title":"Psychiatric aspects of acute porphyria: a comprehensive review","volume":"20","author":"Duque-Serrano","year":"2018","journal-title":"Curr. Psychiatry Rep."},{"year":"1985","series-title":"High Prevalence of Intermittent Acute Porphyria in a Psychiatric Patient Population","author":"Tishler","key":"10.1016\/j.jns.2021.117605_bb0095"},{"key":"10.1016\/j.jns.2021.117605_bb0100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jnnp.62.4.319","article-title":"The little imitator - Porphyria: a neuropsychiatric disorder","volume":"62","author":"Crimlisk","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"journal-title":"Screen. Porphyria Among Psychiatr. Patients","year":"1971","author":"Ottosson","key":"10.1016\/j.jns.2021.117605_bb0105"},{"key":"10.1016\/j.jns.2021.117605_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12991-014-0027-x","article-title":"Psychiatric manifestations of treatable hereditary metabolic disorders in adults","volume":"13","author":"Demily","year":"2014","journal-title":"Ann. General Psychiatry"},{"key":"10.1016\/j.jns.2021.117605_bb0115","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/practneurol-2017-001878","article-title":"Porphyria: often discussed but too often missed","volume":"18","author":"O\u2019Malley","year":"2018","journal-title":"Pract. Neurol."},{"year":"2021","series-title":"Varied Psychiatric Manifestations of Acute Intermittent Porphyria","author":"Santosh","key":"10.1016\/j.jns.2021.117605_bb0120"},{"key":"10.1016\/j.jns.2021.117605_bb0125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1528-1157.1996.tb00018.x","article-title":"Epidemiology and clinical characteristics of seizures in patients with acute intermittent porphyria","volume":"37","author":"Bylesj\u00f6","year":"1996","journal-title":"Epilepsia."},{"key":"10.1016\/j.jns.2021.117605_bb0130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000353279","article-title":"Acute porphyria presenting as epilepsia partialis continua","volume":"5","author":"Tran","year":"2013","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.jns.2021.117605_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ebcr.2018.11.002","article-title":"Nonconvulsive status epilepticus secondary to acute porphyria crisis","volume":"11","author":"Dawit","year":"2019","journal-title":"Epilepsy Behav. Case Reports."},{"key":"10.1016\/j.jns.2021.117605_bb0140","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1468-1331.2004.00876.x","article-title":"Refractory status epilepticus due to acute hepatic porphyria in a pregnant woman: induced abortion as the sole therapeutic option?","volume":"11","author":"Engelhardt","year":"2004","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2021.117605_bb0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2017.09.013","article-title":"Antiepileptic drugs and liver disease","volume":"77","author":"Vidaurre","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jns.2021.117605_bb0150","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1212\/WNL.30.6.588","article-title":"Seizure management in acute hepatic porphyria: risks of valproate and clonazepam","volume":"30","author":"Bonkowsky","year":"1980","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2021.117605_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/j.1528-1157.1992.tb02291.x","article-title":"Acute intermittent porphyria and epilepsy: safety of clonazepam","volume":"33","author":"Suzuki","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2021.117605_bb0160","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1212\/WNL.28.8.824","article-title":"Posttraumatic epilepsy and acute intermittent porphyria: effects of phenytoin, carbamazepine, and clonazepam","volume":"28","author":"Larson","year":"1978","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2021.117605_bb0165","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2125.1997.t01-1-00609.x","article-title":"Drug treatment in acute porphyria","volume":"44","author":"Gorchein","year":"1997","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jns.2021.117605_bb0170","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1528-1157.2001.44200.x","article-title":"Oxcarbazepine in focal epilepsy and hepatic porphyria: a case report","volume":"42","author":"Gaida-Hommernick","year":"2001","journal-title":"Epilepsia."},{"key":"10.1016\/j.jns.2021.117605_bb0175","doi-asserted-by":"crossref","DOI":"10.1136\/practneurol-2015-001305","article-title":"Safe use of perampanel in a carrier of variegate porphyria","volume":"16","author":"Balestrini","year":"2016","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.jns.2021.117605_bb0180","doi-asserted-by":"crossref","DOI":"10.1111\/j.0013-9580.2004.00204.x","article-title":"Levetiracetam in focal epilepsy and hepatic porphyria: a case report","volume":"45","author":"Paul","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2021.117605_bb0185","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.21037\/atm-20-1529","article-title":"Management of hyponatremia associated with acute porphyria\u2014proposal for the use of tolvaptan","volume":"8","author":"Solares","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jns.2021.117605_bb0190","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s002340050852","article-title":"Acute intermittent porphyria with central pontine myelinolysis and cortical laminar necrosis","volume":"41","author":"Susa","year":"1999","journal-title":"Neuroradiology."},{"key":"10.1016\/j.jns.2021.117605_bb0195","first-page":"242","article-title":"Acute intermittent porphyria with central pontine myelinolysis and cortical laminar necrosis","volume":"11","author":"Soysal","year":"2017","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2021.117605_bb0200","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ana.20432","article-title":"Acute intermittent porphyria presenting as a diffuse encephalopathy","volume":"57","author":"Maramattom","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2021.117605_bb0205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.33588\/rn.3803.2003342","article-title":"A reversible posterior leukoencephalopathy syndrome","volume":"38","author":"L\u00f3pez-Garc\u00eda","year":"2004","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.jns.2021.117605_bb0210","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.autrev.2015.05.006","article-title":"Posterior reversible encephalopathy syndrome-insight into pathogenesis, clinical variants and treatment approaches","volume":"14","author":"Granata","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jns.2021.117605_bb0215","doi-asserted-by":"crossref","DOI":"10.1097\/WCO.0000000000000640","article-title":"Posterior reversible encephalopathy syndrome","volume":"32","author":"Liman","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jns.2021.117605_bb0220","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1445-5994.2008.01778.x","article-title":"Nitric oxide and the clinical manifestations of acute porphyria","volume":"38","author":"Thachil","year":"2008","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.jns.2021.117605_bb0225","series-title":"Transient Cortical Blindness and Bioccipital Brain Lesions in Two Patients with Acute Intermittent Porphyria","first-page":"598","volume":"123","author":"Kupferschmidt","year":"1995"},{"key":"10.1016\/j.jns.2021.117605_bb0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jphotobiol.2013.06.014","article-title":"Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall","volume":"126","author":"Middelburg","year":"2013","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.jns.2021.117605_bb0235","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1552-6569.2010.00497.x","article-title":"The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: A retrospective series of 24 patients","volume":"21","author":"Ni","year":"2011","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.jns.2021.117605_bb0240","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ymgme.2019.10.011","article-title":"Porphyria-induced posterior reversible encephalopathy syndrome and central nervous system dysfunction","volume":"128","author":"Jaramillo-Calle","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jns.2021.117605_bb0245","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/practneurol-2012-000288","article-title":"Cerebral vasospasm and anterior circulation stroke secondary to an exacerbation of hereditary corproporphyria","volume":"12","author":"Mullin","year":"2012","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.jns.2021.117605_bb0250","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/ene.13347","article-title":"Cerebral vasospasm in acute porphyria","volume":"24","author":"Olivier","year":"2017","journal-title":"Eur. J. Neurol."},{"year":"2016","series-title":"Acute Intermittent Porphyria-Related Leukoencephalopathy","author":"Kevelam","key":"10.1016\/j.jns.2021.117605_bb0255"},{"key":"10.1016\/j.jns.2021.117605_bb0260","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1055\/s-0039-1693006","article-title":"Inherited neuropathies","volume":"39","author":"Carroll","year":"2019","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.jns.2021.117605_bb0265","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/mus.20137","article-title":"Porphyric neuropathy","volume":"30","author":"Albers","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2021.117605_bb0270","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/brain\/awn152","article-title":"Nerve function and dysfunction in acute intermittent porphyria","volume":"131","author":"Lin","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jns.2021.117605_bb0275","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/mus.880010405","article-title":"Electrodiagnostic findings in acute porphyric neuropathy","volume":"1","author":"Albers","year":"1978","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2021.117605_bb0280","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/jnnp.48.10.1025","article-title":"Autonomic neuropathy in acute intermittent porphyria","volume":"48","author":"Laiwah","year":"1985","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2021.117605_bb0285","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1093\/brain\/awh235","article-title":"Assessing function and pathology in familial dysautonomia: assessment of temperature perception, sweating and cutaneous innervation","volume":"127","author":"Hilz","year":"2004","journal-title":"Brain."},{"key":"10.1016\/j.jns.2021.117605_bb0290","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1445-5994.1981.tb03745.x","article-title":"An acute attack of variegate porphyria complicated by severe autonomic neuropathy","volume":"11","author":"Stewart","year":"1981","journal-title":"Aust. NZ J. Med."},{"key":"10.1016\/j.jns.2021.117605_bb0295","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/jama.1990.03450100080031","article-title":"Acute intermittent porphyria","volume":"264","author":"Sack","year":"1990","journal-title":"JAMA."},{"key":"10.1016\/j.jns.2021.117605_bb0300","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jocn.2006.11.015","article-title":"Neurological complications of porphyria","volume":"15","author":"Solinas","year":"2008","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2021.117605_bb0305","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1440-1789.2006.00751.x","article-title":"Acute intermittent porphyria with peripheral neuropathy complicated by small-fiber neuropathy","volume":"27","author":"Hsieh","year":"2007","journal-title":"Neuropathology."},{"key":"10.1016\/j.jns.2021.117605_bb0310","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00316572","article-title":"Electromyogram and nerve conduction in patients with acute intermittent porphyria","volume":"214","author":"Flugel","year":"1977","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.117605_bb0315","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/bmj.2.5966.310","article-title":"Neuropathy in latent hereditary hepatic porphyria","volume":"2","author":"Mustajoki","year":"1975","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jns.2021.117605_bb0320","first-page":"73","article-title":"Study of motor and sensory nerve conduction velocities, late responses (F-wave and H-reflex) and somatosensory evoked potential in latent phase of intermittent acute porphyria","volume":"40","author":"Kochar","year":"2000","journal-title":"Electromyogr. Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2021.117605_bb0325","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2796.2000.00697.x","article-title":"Signs of neuropathy in the lower legs and feet of patients with acute intermittent porphyria","volume":"248","author":"Wikberg","year":"2000","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jns.2021.117605_bb0330","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/mus.880170715","article-title":"Acute peripheral neuropathy due to hereditary coproporphyria","volume":"17","author":"Barohn","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2021.117605_bb0335","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1212\/WNL.58.7.1118","article-title":"Porphyria presenting with bilateral radial motor neuropathy: evidence of a novel gene mutation","volume":"58","author":"King","year":"2002","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2021.117605_bb0340","doi-asserted-by":"crossref","first-page":"283","DOI":"10.7196\/SAMJ.7785","article-title":"Acute intermittent porphyria presenting as progressive muscular atrophy in a young black man","volume":"104","author":"Albertyn","year":"2014","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.jns.2021.117605_bb0345","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/brain\/80.2.176","article-title":"Changes in the nervous system in acute porphyria","volume":"80","author":"Hierons","year":"1957","journal-title":"Brain."},{"key":"10.1016\/j.jns.2021.117605_bb0350","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00690977","article-title":"Peripheral nerve changes in porphyric neuropathy: findings in a sural nerve biopsy","volume":"42","author":"Anzil","year":"1978","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2021.117605_bb0355","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF00695599","article-title":"An autopsy case of acute porphyria with a decrease of both uroporphyrinogen I synthetase and ferrochelatase activities","volume":"64","author":"Yamada","year":"1984","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2021.117605_bb0360","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(96)09070-8","article-title":"The acute porphyrias","volume":"349","author":"Elder","year":"1997","journal-title":"Lancet."},{"key":"10.1016\/j.jns.2021.117605_bb0365","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barre syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.jns.2021.117605_bb0370","first-page":"310","article-title":"Cerf, [Rhabdomyolysis in acute intermittent porphyria]","volume":"16","author":"Devars du Mayne","year":"1987","journal-title":"Presse Med."},{"key":"10.1016\/j.jns.2021.117605_bb0375","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1258\/0004563041201563","article-title":"Rhabdomyolysis in a patient with acute intermittent porphyria","volume":"41","author":"Marsden","year":"2004","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.jns.2021.117605_bb0380","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1399-0004.2008.01061.x","article-title":"A novel 19-bp deletion of exon 15 in the HMBS gene causing acute intermittent porphyria associating with rhabdomyolysis during an acute attack","volume":"74","author":"Yrjonen","year":"2008","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jns.2021.117605_bb0385","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/MCG.0000000000000264","article-title":"R173W mutation of hydroxymethylbilane synthetase is associated with acute intermittent porphyria complicated with rhabdomyolysis: the first report","volume":"49","author":"Chen","year":"2015","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.jns.2021.117605_bb0390","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1182\/blood-2012-05-423186","article-title":"The porphyrias: advances in diagnosis and treatment","volume":"120","author":"Balwani","year":"2012","journal-title":"Blood."},{"author":"Anderson","key":"10.1016\/j.jns.2021.117605_bb0395"},{"key":"10.1016\/j.jns.2021.117605_bb0400","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1212\/WNL.27.11.1053","article-title":"Effect of hematin in porphyric neuropathy","volume":"27","author":"Bosch","year":"1977","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2021.117605_bb0405","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2796.1993.tb01022.x","article-title":"Porphyric neuropathy: prevention of progression using haeme-arginate","volume":"234","author":"Muthane","year":"1993","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jns.2021.117605_bb0410","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jns.2007.03.018","article-title":"Acute intermittent porphyria with peripheral neuropathy: a follow-up study after hematin treatment","volume":"260","author":"Kuo","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2021.117605_bb0415","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/lt.21261","article-title":"Liver transplantation for porphyria: who, when, and how?","volume":"13","author":"Seth","year":"2007","journal-title":"Liver Transpl."},{"key":"10.1016\/j.jns.2021.117605_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(04)15646-8","article-title":"Liver transplantation as a cure for acute intermittent porphyria","volume":"363","author":"Soonawalla","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2021.117605_bb0425","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N -acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jns.2021.117605_bb0430","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa1807838","article-title":"Phase 1 trial of an RNA interference therapy for acute intermittent Porphyria","volume":"380","author":"Sardh","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2021.117605_bb0435","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa1913147","article-title":"Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria","volume":"382","author":"Balwani","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21002999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21002999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:57:14Z","timestamp":1758383834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21002999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":87,"alternative-id":["S0022510X21002999"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.117605","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurology of the acute hepatic porphyrias","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.117605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117605"}}